Roche’s Genentech is ending a partnership with Nykode Therapeutics that centered around a clinical-stage cancer vaccine ...

Nykode Therapeutics (VACBF) announced last night that it has received notification from Genentech, a member of the Roche (RHHBY), of its ...

Genentech, a member of the Roche (RHHBY), announced that it will present more than 40 abstracts across nine blood disorders at the 66th ...

Genentech to Present New and Encouraging Long-term Follow-up Data Across Broad Hematology Portfolio at ASH 2024 ...

Audi is making a big change to its branding for the Chinese market with a new logo that lacks the automaker’s famous ...

The news: Audi has just launched a new EV brand in China, and the company is making a bold branding move to set the vehicles ...

At the heart of the alliance is the ‘lab-in-the-loop’ concept pioneered at Genentech’s Prescient Design accelerator unit. In a nutshell, that involves drawing on the company’s rich source ...

Erin Dueber, Ph.D. is a Distinguished Scientist and Director of the Biological Chemistry Department, with a joint appointment in the Structural Biology Department, at Genentech in South San Francisco, ...

Here are some fun videos for you to watch created by graphic designer Kostya Petrenko. He has been creating retro 1980s-style logos for modern brands like Netflix, Spotify, Google, and OpenAI. Some of ...

It also comes after a pledge by the company to plough savings from a cost-reduction drive back into its pipeline. The three platform deals are long-term bets, but broaden Genentech’s drug ...

Rivian’s R2 vehicles will be powered by batteries made domestically in the US by South Korea’s LG Energy Solution, the ...

The ROS-1 NSCLC current market is mainly dominated by tyrosine kinase inhibitors such as XALKORI at present and is anticipated to be dominated by Repotrectinib, Taletrectinib, and NVL-520 by 2034.